Cushing's disease (CD) in adolescence and childhood is a rare pathology and has some different clinical and therapeutic characteristics than in adults. We report 3 cases treated surgically, with the diagnosis of CD. Their common complaints were short stature and obesity. Endocrinological investigations and radiological evaluation pointed out the diagnosis of CD for all children. They were operated on by the transsphenoidal route, and adenoma resection was performed. Histopathologic and immunohistochemical examination of the tissue specimens confirmed the diagnosis of CD. Long-term follow-up demonstrated weight loss and increase in height.

Weber A, Trainer PJ, Grossman AB: Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing’s syndrome. Clin Endocrinol (Oxf) 1995;43:19–28.
Robyn JA, Koch CA, Montalto J, Yong A, Wame GL, Batch JA: Cushing’s syndrome in childhood and adolescence. J Pediatr Child Health 1997;33:522–527.
Bonicki W, Dowzenko A, Koszewski W: Importance of catheterization of inferior petrous sinuses in surgical treatment of Cushing’s in children and adolescents. Neurol Neurochir Pol 1995;29:729–736.
Medrano J, Eigler FW, Jakubowski HD: Operable forms of hypertension in childhood. Monatsschr Kinderheilk 1977;125:376–378.
Leinung MC, Zimmerman D: Cushing’s disease in children. Endocrinol Metab Clin North Am 1994;23:629–639.
Leinung MC, Kane LA, Scheithauer BW, Carpenter PC, Laws ER Jr, Zimmerman D: Long term follow up of transsphenoidal surgery for the treatment of Cushing’s disease in childhood. J Clin Endocrinol Metab 1995;80:2475–2479.
Houwen RH, Drop SI, Hazebroek FW, ten Kate FW: Pituitary dependant Cushing’s disease and primary adrenocortical nodular dysplasia in childhood. Eur J Pediatr 1983;141:101–108.
Partington MD, Davis DH, Laws ER Jr, Scheithauer BW: Pituitary adenomas in childhood and adolescence. Results of transsphenoidal surgery. J Neurosurg 1994;80:209–216.
Barrios Castellanos R, Argente Oliver J, Alonso BM, Yturriaga MR: Cushing’s disease in childhood: Apropos of a case cured after transsphenoidal adenomectomy. An Esp Pediatr 1984;20:387–394.
Thomas CG Jr, Smith AT, Benson M, Griffith J: Nelson’s syndrome after Cushing’s disease in childhood: A continuing problem. Surgery 1984;96:1067–1077.
Styne DM, Grumbach MM, Kaplan SL, Wilson CB, Conte FA: Treatment of Cushing’s disease in childhood and adolescence by transsphenoidal microadenomectomy. N Engl J Med 1984;310:889–893.
Jennings AS, Little GW, Orth DN: Results of treating childhood Cushing’s disease with pituitary irradiation. N Engl J Med 1977;297:957–962.
Thoren M, Rahn T, Hallengren B: Treatment of Cushing’s disease in childhood and adolescence by stereotactic irradiation. Acta Pediatr Scand 1986;75:388–395.
McArthur RG, Hayles AB, Salassa RM: Childhood Cushing’s disease: Results of bilateral adrenalectomy. J Pediatr 1979;95:214–219.
Weisman MN, Page LK, Bejar RL: Cushing’s disease in childhood: Benign intracranial hypertension after transsphenoidal adenomectomy. Case report. Neurosurgery 1983;13:195–198.
Desai M, Colaco M, Merchant SM: Cushing’s syndrome in childhood. Indian J Pediatr 1982;49:457–460.
D’Ercole AJ, Morris MA, Underwood LE, van Wyk JJ, Feldman JM: Treatment of Cushing’s disease in childhood with cyproheptadine. J Pediatr 1977;90:834–835.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.